For Ever has entered into a strategic partnership with Synergia Capital Partners
For Ever, the global market leader in gladiolus breeding, has entered into a strategic partnership with Synergia Capital Partners B.V. With this investment, the company will continue the strong growth of recent years.
Based in the Netherlands, For Ever was established in 1998, when three gladiolus breeders brought their genetics into one company. The merger aimed to create economies of scale, which has resulted in the company’s current dominant position in the sector. Breeding is the process of developing and producing new plant species. For Ever has developed unique gladiolus varieties that are appreciated by its customers all over the world. On the back of its number one position, For Ever is well positioned to benefit from the current market dynamics and increase its market share.
Synergia Capital Partners is an investment company funded by successful Dutch entrepreneurs which invests in companies based on the premise that a combination of knowledge and capital will lead to success. One of their focus sectors is agriculture, and with a strong track record within the space, Synergia is believed to have the right capabilities and experience to support For Ever in realizing its strategic goals.
Oaklins’ team in the Netherlands served as the exclusive sell-side advisors to For Ever in this transaction.
Theo van Aanholt
Director, For Ever
Talk to the deal team
Frank de Hek
Casper Oude Essink
Senior AssociateAmsterdam, Netherlands
Daphne van der Bilt
Bonnier Corporation has sold seven of its US titles to North Equity
Bonnier Corporation has sold seven of its most popular US titles, including Popular Science, Popular Photography, Saveur, Outdoor Life, Field & Stream, Better You and Interesting Things, to venture equity group North Equity.Learn more
RVC Medical IT has been acquired by NEXUS AG
Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.Learn more
Listan, a leading provider of high-performance computer components, has been acquired by Afinum
The three founders of Listan GmbH have sold a majority stake in the company to Afinum.Learn more